KMX INVESTORS: BFA Law Reminds CarMax, Inc. Investors with Losses to Contact the Firm before the Imminent January 2 Securities Class Action DeadlineNovember 20, 2025 3:46 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant ...

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit. In ...

Core Viewpoint - CarMax, Inc. is facing a class action lawsuit for securities fraud following a significant drop in stock price attributed to misleading statements regarding demand and financial performance [2][4]. Group 1: Lawsuit Details - A class action lawsuit has been filed against CarMax and its senior executives for securities fraud, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [4]. - Investors have until January 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [4]. - The lawsuit alleges that CarMax misled investors about the sustainability of demand for its vehicles, particularly in light of U.S. tariffs on cars [5]. Group 2: Financial Performance - CarMax reported disappointing financial results for Q2 of fiscal year 2026, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [7]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million in the previous year [7]. - The decline in sales was attributed to a "pull forward" in demand due to the announcement of tariffs, which led to a temporary increase in purchases before the tariffs took effect [7]. Group 3: Stock Price Reaction - Following the disappointing financial results announced on September 25, 2025, CarMax's stock price dropped by $11.45 per share, or roughly 20%, from $57.05 to $45.60 [8]. - An additional drop of over 24% occurred after the unexpected departure of CEO Bill Nash on November 6, 2025, along with a weak preliminary outlook for Q3 2025 [8].

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. and certain senior executives for securities fraud following a significant drop in stock price due to potential violations of federal securities laws [1][2]. Group 1: Lawsuit Details - Investors have until January 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [2]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of CarMax investors [2]. Group 2: Reasons for the Lawsuit - CarMax has been accused of misleading investors about the demand for its used cars, which was allegedly inflated by short-term factors such as U.S. tariffs [3]. - The company reported disappointing financial results for Q2 FY 2026, including a 5.4% decline in retail used unit sales and a net income drop from $132.8 million to $95.4 million year-over-year [5]. Group 3: Stock Performance - Following the announcement of poor financial results on September 25, 2025, CarMax's stock price fell by $11.45, or approximately 20%, from $57.05 to $45.60 per share [6]. - The unexpected departure of CEO Bill Nash on November 6, 2025, along with a weak preliminary Q3 2025 outlook, led to an additional stock drop of over 24% [6].

Core Viewpoint - Beyond Meat, Inc. is under investigation for potential violations of federal securities laws, particularly concerning the inflation of the value of certain long-lived assets [1][3]. Financial Performance and Stock Movement - On October 24, 2025, Beyond Meat announced an expected non-cash impairment charge for the three months ended September 27, 2025, related to certain long-lived assets, which was anticipated to be material. This announcement led to a significant stock price drop of approximately 23%, from $2.84 per share on October 23, 2025, to $2.185 per share on October 24, 2025 [4]. - Following the impairment announcement, the company delayed its earnings announcement for Q3 2025 on November 3, 2025, due to the need for additional time to complete the impairment review, resulting in further declines in stock price during trading on that day [5]. Company Operations and Asset Management - In late 2023, Beyond Meat conducted a global operations review and depreciated certain long-lived assets, stating that these assets were recorded at the lower of their carrying value or fair value less costs to sell, with no impairments reported [2].

Core Viewpoint - A class action securities lawsuit has been filed against Cytokinetics, alleging securities fraud related to misleading statements about the New Drug Application (NDA) for aficamten, which affected investors between December 27, 2023, and May 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Cytokinetics made materially false and misleading statements regarding the expected timeline for FDA approval of aficamten, indicating approval in the second half of 2025 based on a September 26, 2025 PDUFA date [2]. - It is alleged that the company failed to disclose significant risks associated with not submitting a Risk Evaluation and Mitigation Strategy (REMS), which could delay the regulatory process [2]. - During an earnings call on May 6, 2025, it was revealed that the company had discussions with the FDA about safety monitoring and risk mitigation but chose to submit the NDA without a REMS, misleading investors about the regulatory timeline [2]. Group 2: Investor Information - Investors who suffered losses in Cytokinetics during the specified timeframe have until November 17, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Insights - Tronox Holdings plc (NYSE: TROX) is facing a class action lawsuit due to allegations of providing misleading statements about its financial health and sales forecasts, particularly regarding its TiO2 and zircon products [2][4] - The company reported a significant decline in TiO2 sales for Q2 2025, attributing this to a weaker coatings season and increased competition, leading to a downward revision of its 2025 financial outlook and a 60% reduction in dividends [2][3] - Following the announcement of poor financial results, Tronox's stock price plummeted approximately 38% from $5.14 to $3.19 per share in just one day [2] Company Overview - Tronox's class period for the lawsuit is defined as February 12, 2025, to July 30, 2025, during which shareholders are encouraged to register for potential recovery [3] - The Gross Law Firm is representing the shareholders, emphasizing its commitment to protecting investors from deceitful practices and ensuring corporate accountability [4] Next Steps for Shareholders - Shareholders who purchased shares during the specified class period must register by November 3, 2025, to be considered for lead plaintiff status, with no cost or obligation to participate [3]

Core Points - A class action securities lawsuit has been filed against Fly-E Group, Inc. for alleged securities fraud affecting investors between July 15, 2025, and August 14, 2025 [1][2] - The lawsuit claims that Fly-E made misleading statements regarding the safety of its lithium batteries, which negatively impacted its electric vehicle sales revenue [2] - On August 14, 2025, Fly-E reported a 32% decrease in net revenues, primarily due to a drop in units sold, attributed to recent lithium battery accidents [2] - Following this disclosure, Fly-E's stock price plummeted approximately 87%, from $7.76 to $1.00 per share in one day [2] Case Details - The lawsuit seeks to recover losses for investors who were misled by Fly-E's positive statements while concealing material adverse facts [2] - The company’s revenue projections were significantly derailed due to increasing operating expenses and declining sales [2] - Investors have until November 10, 2025, to request to be appointed as lead plaintiff in the case [3] Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

Core Points - A class action securities lawsuit has been filed against Fly-E Group, Inc. for alleged securities fraud affecting investors between July 15, 2025, and August 14, 2025 [1][2] - The lawsuit claims that Fly-E made misleading statements regarding the safety of its lithium batteries, which negatively impacted E-vehicle sales revenue, despite optimistic long-term projections [2] - On August 14, 2025, Fly-E reported a 32% decrease in net revenues, primarily due to a drop in total units sold, linked to recent lithium-battery accidents [2] - Following this announcement, Fly-E's stock price plummeted approximately 87%, from $7.76 per share to $1.00 per share in one day [2] Case Details - The lawsuit seeks to recover losses for investors who were adversely affected by the alleged fraud during the specified period [1] - Investors have until November 10, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as a leading securities litigation firm in the U.S. [4]

Core Viewpoint - Tronox Holdings plc is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 12, 2025, and July 30, 2025 [1][2]. Company Performance - The lawsuit claims that Tronox provided overly positive statements while concealing material adverse facts about its commercial division and demand forecasting for its products [2]. - On July 30, 2025, Tronox reported a significant decline in TiO2 sales, attributing it to a "softer than anticipated coatings season and heightened competitive dynamics" [2]. - Following the disappointing financial results, Tronox lowered its full-year revenue guidance and reduced its dividend by 60% [2]. Stock Market Reaction - Tronox's stock price fell dramatically from $5.14 per share on July 30, 2025, to $3.19 per share on July 31, 2025, marking a decline of approximately 38% in just one day [2]. Legal Proceedings - Investors who suffered losses during the relevant time frame have until November 3, 2025, to request to be appointed as lead plaintiff in the class action [3]. - Participation in the lawsuit does not require investors to incur any out-of-pocket costs or fees [3]. Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4].